In addition, Khoshbaten et al. examined the efficacy of 3 months of NAC (600 mg per 12 h) treatment in 15 NAFLD patients and found significantly decreased serum ALT levels by NAC treatment (Khoshbaten et al., 2010). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.